2022
DOI: 10.1016/j.taap.2021.115818
|View full text |Cite
|
Sign up to set email alerts
|

Effects of tyrosine kinase inhibitors on androgen, estrogen α, glucocorticoid and thyroid receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 80 publications
0
1
0
Order By: Relevance
“…It is still one of the most commonly used anticancer drugs in European countries [ 1 ]. Currently, 48 drugs targeting TKs have been approved for clinical use by the U.S. Food and Drug Administration, and many more are in clinical trials [ 5 ]. Therefore, it is expected that as the clinical use of TKIs increases, the occurrence of their residues in the aquatic environment will also increase each year.…”
Section: Introductionmentioning
confidence: 99%
“…It is still one of the most commonly used anticancer drugs in European countries [ 1 ]. Currently, 48 drugs targeting TKs have been approved for clinical use by the U.S. Food and Drug Administration, and many more are in clinical trials [ 5 ]. Therefore, it is expected that as the clinical use of TKIs increases, the occurrence of their residues in the aquatic environment will also increase each year.…”
Section: Introductionmentioning
confidence: 99%